Transparent reporting of trials is essential

American Journal of Gastroenterology

Volumn 108, Issue 8, 2013, Pages 1231-1235

  Altman, Douglas G ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PRACTICE; CLINICAL RESEARCH; COMPARATIVE STUDY; HUMAN; INFORMATION PROCESSING; MANAGEMENT; OUTCOME ASSESSMENT; PATIENT SAFETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELIABILITY;

CHECKLIST; GUIDELINE ADHERENCE; GUIDELINES AS TOPIC; HUMANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PEER REVIEW, RESEARCH; PERIODICALS AS TOPIC; PUBLISHING; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; RESEARCH REPORT;

EID: 84881120657     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.457     Document Type: Article

References (28)

1. Sackett DL. Rational therapy in the neurosciences: the role of the randomized trial. Stroke 1986;17:1323-9.
2. Moher D, Hopewell S, Schulz KF et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c869.
3. Boutron I, Dutton S, Ravaud P et al. Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA 2010;303:2058-64.
4. You B, Gan HK, Pond G et al. Consistency in the analysis and reporting of primary end points in oncology randomized controlled trials from registration to publication: a systematic review. J Clin Oncol 2012;30:210-6.
5. Higgins JP, Altman DG, Gotzsche PC et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.
6. Dechartres A, Charles P, Hopewell S et al. Reviews assessing the quality or the reporting of randomized controlled trials are increasing over time but raised questions about how quality is assessed. J Clin Epidemiol 2011;64:136-44.
7. Hopewell S, Dutton S, Yu LM et al. The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed. BMJ 2010;340:c723.
8. Duff JM, Leather H, Walden EO et al. Adequacy of published oncology randomized controlled trials to provide therapeutic details needed for clinical application. J Natl Cancer Inst 2010;102:702-5.
9. Glasziou P, Meats E, Heneghan C et al. What is missing from descriptions of treatment in trials and reviews? BMJ 2008;336:1472-4.
10. Ioannidis JP. Adverse events in randomized trials: neglected, restricted, distorted, and silenced. Arch Intern Med 2009;169:1737-9.
11. Dwan K, Altman DG, Arnaiz JA et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One [online] 2008;3:e3081.
12. Mathieu S, Boutron I, Moher D et al. Comparison of registered and published primary outcomes in randomized controlled trials. JAMA 2009;302:977-84.
13. Huic M, Marusic M, Marusic A. Completeness and changes in registered data and reporting bias of randomized controlled trials in ICMJE journals after trial registration policy. PLoS One [online] 2011;6:e25258.
14. Hill AB. The reasons for writing. BMJ 1965;2:870-1.
15. International Committee of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication. http://www.icmje.org/urm-full.pdf
16. Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 2010;152:726-32.
17. Schulz KF, Altman DG, Moher D et al. CONSORT 2010 changes and testing blindness in RCTs. Lancet 2010;375:1144-6.
18. Hopewell S, Hirst A, Collins GS et al. Reporting of participant flow diagrams in published reports of randomized trials. Trials [online] 2011;12:253.
19. Bailar JC. How to distort the scientific record without actually lying: truth, and the arts of science. Eur J Oncol 2006;11:217-24.
20. Dancey JE. From quality of publication to quality of care: translating trials to practice. J Natl Cancer Inst 2010;102:670-1.
21. Larson EL, Cortazal M. Publication guidelines need widespread adoption. J Clin Epidemiol 2012;65:239-46.
22. Gotzsche PC. Why we need easy access to all data from all clinical trials and how to accomplish it. Trials [online] 2011;12:249.
23. Ross JS, Tse T, Zarin DA et al. Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis. BMJ 2012;344:d7292.
24. Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Lancet 2009;374:86-9.
25. Simera I, Moher D, Hirst A et al. Transparent and accurate reporting increases reliability, utility, and impact of your research: reporting guidelines and the EQUATOR Network. BMC Med [online] 2010;8:24.
26. Rippel RA. Re: Effect of using reporting guidelines during peer review on quality of final manuscripts submitted to a biomedical journal: masked randomised trial. BMJ 2011;343:d6783.
27. Rupinski M, Zagorowicz E, Regula J et al. Randomized comparison of three palliative regimens including brachytherapy, photodynamic therapy, and APC in patients with malignant dysphagia (CONSORT 1a) (Revised II). Am J Gastroenterol 2011;106:1612-20.
28. Cobo E, Cortes J, Ribera JM et al. Effect of using reporting guidelines during peer review on quality of final manuscripts submitted to a biomedical journal: masked randomised trial. BMJ 2011;343:d6783.